This article gives a detailed description of the procedure the occupational physician uses in interpreting the available scientific data to provide useful information for prevention of pulmonary diseases related to man-made mineral fibers, particularly lung cancer and mesothelioma. As it is difficult to reach definite conclusions from human data on the toxicity of specific fibers, an experimental approach is needed. Concerning animal data, we emphasize that adequate inhalation studies are the "gold standard" for extrapolating to humans. However, experiments using intracavitary injection or cells in vitro may represent indicative tests for a possible carcinogenic effect. Such tests should be used to assess the intrinsic carcinogenicity of fibers, but they must be confirmed by adequate inhalation models. Despite the present uncertainties, a proposal is made that could make it possible to classify fibers according to their toxicologic potential, grading them in accordance with physicochemical parameters, in vitro testing, and animal experiments. This procedure may be applicable to nonvitreous fibers and to organic fibers. -Environ Health Perspect 102(Suppl 5):31-36 (1994) 
Introduction
One of the main objectives of a public health physician is to transform scientific data into information useful for prevention of disease. The occupational physician is a public health physician who specializes in occupational health. This presentation will focus on the consequences of exposure of workers to man-made vitreous fibers (MMVF) as seen from the occupational physician's point of view.
This approach is based on the circumstances in which the problem is raised at the workplace. Usually the occupational physician is alerted by the presence of fiber-containing products at some level of work activity, either because of the introduction of a new product or because of any intervention by a worker on an old fibercontaining material. The physician then has to identify the fibers either from information obtained from the producer-such as the health and security data sheet or product label-or, especially in the case of old materials, from bulk analysis. The has to make a risk extrapolation or initiate a toxicological evaluation. Depending on the toxicologist's answer, the physician makes a risk assessment of the situation at the workplace, taking into account the level of exposure and the medical status of the workers. This is possible only if information is available on a dose-response relationship and, particularly, if threshold limit values apply. Finally, he can establish a prevention program.
The aim of this presentation is to determine how the occupational physician could use the available scientific information concerning MMVF. To answer this point, we will discuss the topics concerning fiber identification, fiber toxicology, and evaluation of fiber-containing products, including the possible interpretation of biopersistence relative to each topic. In the light of this discussion, we propose a systematic method of assessment of the carcinogenic potential of MMVF.
Fiber Identification
A major effort has been made to classify fibers. However, two questions must be posed: First, can existing classifications include any existing or newly developed commercial fiber? Second, are commercial and technical classifications compatible with toxicological data?
Three organizations have proposed classifications that are in use: The American Thermal Insulation Manufacturers Association (TIMA) has proposed a tree to define the man-made vitreous fibers, according to their origin, their physicochemical composition, and the process of production (1) . The ultimate subdivision of man-made mineral fibers has been used by the International Programme on Chemical Safety (IPCS). However, this classification is built mainly on a commercial basis, and some glass fibers of the same chemical composition are found in different groups. In other cases fibers with different chemical compositions can fall into the same category (2). The classification used by the International Agency for Research on Cancer (IARC) was intended to integrate toxicological and epidemiological information, but it will now be difficult to include new data relating, for example, to special purpose fibers (3) . None of these classifications seems completely adapted to a precise identification of a fiber, or a close match with toxicological data.
Fiber Toxicology
Detailed toxicological results are discussed elsewhere in these proceedings. Here, we consider only the data that may pose problems to the occupational physician.
Human Mortality Studies
Data on mortality have been obtained exclusively among manufacturing industries (4) (5) (6) . They have demonstrated a small excess of lung cancer in the groups with the longest duration of exposure, at least for those exposed to rockwool or slagwool and to some superfine glass fibers. It is, however, very difficult from those data to distinguish clearly the role of each type of fiber. This is particularly needed for the Environmental Health Perspectives rockwool and slagwool group. In addition, discussions concerning the influence of the confounding factors on the available results are not closed (7) (8) (9) (10) . In any case, two points have to be reassessed: First, industrial hygiene data suggest that the level of exposure could be higher among end-users than among workers in the manufacturing industry (11) ; and second, due to the short survey period on the one hand and, on the other, the relatively small number of person-years in the groups derived from workers for whom the duration since the beginning of exposure was more than 30 years, it would not be possible to detect a low but significant excess risk of mesothelioma on the basis of the available data.
Morbidity Data
The most pertinent morbidity data are for workers exposed to insulation wool and refractory ceramic fibers. Results from the update of the American "insulation wool" study still are not available (12, 13) , while conflicting results are reported among the two European and American "ceramic" cohorts. Preliminary findings of an excess of pleural plaques in the American cohort seems to be very important in view of the relatively short duration of exposure in that cohort and the small numbers involved (14) . An updating of the European cohort 5 years after the first survey should be very informative (15) .
Human Data on Biopersistence
These data are still difficult to interpret. On the one hand, in the study made with the available lung tissue taken at autopsy from the American cohort, mineral vitreous fibers were so modified that it was impossible to make a precise identification of the siliceous fibers (16 
Intracavitay Models
Some of the same fibers as those used in the RCC (Geneva), study have been tested in intracavitary models. Even though comparison is difficult because fibers were not of the same origin, the studies reported in Table 2 using intrapleural administration have confirmed that ceramic fibers were more toxic than the others (22) (23) (24) (25) . Classification of the results as negative, doubtful, or positive was made according to criteria proposed elsewhere (26) .
More interesting are the results observed with intraperitoneal administration (Table 3) . The results show a strongly positive response from ceramic fiber and an intermediate response from the rockwool fibers tested. These perhaps were not the same fibers as those used in the inhalation study, but the two results may still be considered complementary (20, (27) (28) (29) (30) .
If this estimation is confirmed, it could increase the significance of results obtained with fibers tested only with intracavitary models. In the case of "JM special purpose fine fibers" (Table 4) , positive finding of both intrapleural and intraperitoneal studies should be considered significant even if inadequate inhalation studies showed no carcinogenic effect (20, 24, 27, 29, (31) (32) (33) (34) (35) (36) 
Biopersistence
The only reproducible attempt made to correlate biopersistence rather than durability, and biological effect, was in the Geneva inhalation studies (37, 38) . The existing data show that ceramic fibers are more biopersistent than the glass fibers tested; rockwool is more biopersistent than slagand glasswool and less biopersistent than ceramic fibers.
Are these results sufficient to draw conclusions regarding the role of biopersistence in the biological effects in animal models? Even (25) . bPercent of groups. (27) (28) (29) (30) . bPercent of groups. that does not give a significant result would not be classified. Some authors propose that in such case the classification of the preceding stage should be maintained particularly when the result is not completely negative, as for example, when there is fibrosis in the absence of any significant excess of tumors. In contrast, a positive result will lead to a classification of "definitely carcinogenic in the animal" (EC class 2).
At present, there is still no consensus on the method of carrying out and interpreting inhalation tests. Must a dose-effect relationship be observed? How is it possible to eliminate artifactual responses produced by overload, which could give false positives? What is the lower limit of the internal dose (that is, of fibers retained in the parenchyma or in the parietal pleura) that would make it possible to avoid false nega- While waiting for this validation, and by analogy with asbestos, it would seem desirable to determine, as a priority, the proportion of the mass of fibers <1 pm in diameter in relation to the total mass of sample. In conformity with the spirit of the European directive relating to labeling of preparations, a product containing more than 1 part per thousand by weight of class 2 fibers or one part per 100 of class 3 fibers should be so labeled.
Products Containing Many Fibers or
Other Chemical Substances. The application of the "preparation directive of the EC" would make it possible to choose the correct label in accordance with the criteria already established for mixtures of substances.
Conclusion
The analysis of available data concerning MMVF shows that there are still a number of contradictions and gaps. Nevertheless, the uncertainty that results from these deficiencies must not be used as an excuse by the occupational physician for delay in setting up a preventive strategy. This is particularly true for fibers that are already available commercially.
For this reason, it seems possible to propose an algorithm of decisions leading to a classification of fibers and to labeling of products they contain. This algorithm is based on available data, on the condition that an effort is made to standardize the methods used. It must be usable for already existing fibers as well as for new fibers in preparation.
